{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T22:01:41Z","timestamp":1784671301367,"version":"3.55.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ejmech.2026.118723","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T17:07:41Z","timestamp":1772125661000},"page":"118723","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Discovery of 2-(methylamino)-5,6,7,8-tetrahydropyrido[4,3-d] pyrimidine derivatives as novel HsClpP activators for multiple myeloma therapy"],"prefix":"10.1016","volume":"309","author":[{"given":"Xiang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinglong","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linjie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5389-9513","authenticated-orcid":false,"given":"Tao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhuan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7327-0368","authenticated-orcid":false,"given":"Youfu","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ejmech.2026.118723_bib1","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International myeloma working group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol."},{"issue":"9","key":"10.1016\/j.ejmech.2026.118723_bib2","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1002\/ajh.27422","article-title":"Multiple myeloma: 2024 update on diagnosis, risk-stratification, and management","volume":"99","author":"Rajkumar","year":"2024","journal-title":"Am. J. Hematol."},{"issue":"6","key":"10.1016\/j.ejmech.2026.118723_bib3","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/s41408-022-00695-5","article-title":"Gaps and opportunities in the treatment of relapsed-refractory multiple myeloma: consensus recommendations of the nci multiple myeloma steering committee","volume":"12","author":"Kumar","year":"2022","journal-title":"Blood Cancer J."},{"issue":"3","key":"10.1016\/j.ejmech.2026.118723_bib4","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/s41375-021-01453-5","article-title":"Mortality trends in multiple myeloma after the introduction of novel therapies in the United States","volume":"36","author":"Binder","year":"2022","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.ejmech.2026.118723_bib5","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41572-024-00529-7","article-title":"Multiple myeloma","volume":"10","author":"Malard","year":"2024","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"21","key":"10.1016\/j.ejmech.2026.118723_bib6","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1038\/onc.2013.228","article-title":"Mitochondrial matrix proteases as novel therapeutic targets in malignancy","volume":"33","author":"Goard","year":"2014","journal-title":"Oncogene"},{"issue":"7","key":"10.1016\/j.ejmech.2026.118723_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1002507","article-title":"The mitochondrial unfoldase-peptidase complex clpxp controls bioenergetics stress and metastasis","volume":"14","author":"Seo","year":"2016","journal-title":"PLoS Biol."},{"issue":"4","key":"10.1016\/j.ejmech.2026.118723_bib8","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.drudis.2021.01.007","article-title":"Human clpp protease, a promising therapy target for diseases of mitochondrial dysfunction","volume":"26","author":"Luo","year":"2021","journal-title":"Drug Discov. Today"},{"issue":"1","key":"10.1016\/j.ejmech.2026.118723_bib9","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.bbrc.2017.07.047","article-title":"Increase in proteins involved in mitochondrial fission, mitophagy, proteolysis and antioxidant response in type i endometrial cancer as an adaptive response to respiratory complex i deficiency","volume":"491","author":"Cormio","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"12","key":"10.1016\/j.ejmech.2026.118723_bib10","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1002\/pmic.200401307","article-title":"Proteomic identification of differentially-expressed genes in human gastric carcinomas","volume":"5","author":"Nishigaki","year":"2005","journal-title":"Proteomics"},{"issue":"6","key":"10.1016\/j.ejmech.2026.118723_bib11","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.ccell.2015.05.004","article-title":"Inhibition of the mitochondrial protease clpp as a therapeutic strategy for human acute myeloid leukemia","volume":"27","author":"Cole","year":"2015","journal-title":"Cancer Cell"},{"issue":"11","key":"10.1016\/j.ejmech.2026.118723_bib12","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1158\/1078-0432.CCR-17-3070","article-title":"Oxidative phosphorylation as an emerging target in cancer therapy","volume":"24","author":"Ashton","year":"2018","journal-title":"Clin. Cancer Res."},{"issue":"10","key":"10.1016\/j.ejmech.2026.118723_bib13","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/s41419-020-03062-z","article-title":"Mitochondrial clpp serine protease-biological function and emerging target for cancer therapy","volume":"11","author":"Nouri","year":"2020","journal-title":"Cell Death Dis."},{"issue":"11","key":"10.1016\/j.ejmech.2026.118723_bib14","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1021\/acschembio.9b00347","article-title":"Chemical modulation of human mitochondrial clpp: potential application in cancer therapeutics","volume":"14","author":"Wong","year":"2019","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2026.118723_bib15","doi-asserted-by":"crossref","DOI":"10.1182\/blood.2024026340","article-title":"The mitochondrial protease clpp is a metabolic vulnerability and an immunogenic trigger against multiple myeloma","author":"Perini","year":"2025","journal-title":"Blood"},{"issue":"22","key":"10.1016\/j.ejmech.2026.118723_bib16","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1182\/blood.2024024781","article-title":"Targeting caseinolytic mitochondrial matrix peptidase, a novel contributor to the pathobiology of high-risk multiple myeloma","volume":"145","author":"Qin","year":"2025","journal-title":"Blood"},{"issue":"67","key":"10.1016\/j.ejmech.2026.118723_bib17","doi-asserted-by":"crossref","first-page":"111213","DOI":"10.18632\/oncotarget.22740","article-title":"Alteration of mitochondrial biogenesis promotes disease progression in multiple myeloma","volume":"8","author":"Zhan","year":"2017","journal-title":"Oncotarget"},{"issue":"9","key":"10.1016\/j.ejmech.2026.118723_bib18","doi-asserted-by":"crossref","first-page":"e415","DOI":"10.3324\/haematol.2018.207704","article-title":"A metabolic switch in proteasome inhibitor-resistant multiple myeloma ensures higher mitochondrial metabolism, protein folding and sphingomyelin synthesis","volume":"104","author":"Besse","year":"2019","journal-title":"Haematologica"},{"issue":"8","key":"10.1016\/j.ejmech.2026.118723_bib19","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.chembiol.2018.05.014","article-title":"Acyldepsipeptide analogs dysregulate human mitochondrial clpp protease activity and cause apoptotic cell death","volume":"25","author":"Wong","year":"2018","journal-title":"Cell Chem. Biol."},{"issue":"44","key":"10.1016\/j.ejmech.2026.118723_bib20","doi-asserted-by":"crossref","first-page":"14602","DOI":"10.1002\/anie.201808189","article-title":"Selective activation of human caseinolytic protease p (clpp)","volume":"57","author":"Stahl","year":"2018","journal-title":"Angew Chem. Int. Ed. Engl."},{"issue":"5","key":"10.1016\/j.ejmech.2026.118723_bib21","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1021\/acschembio.9b00222","article-title":"Mitochondrial protease clpp is a target for the anticancer compounds onc201 and related analogues","volume":"14","author":"Graves","year":"2019","journal-title":"ACS Chem. Biol."},{"issue":"4","key":"10.1016\/j.ejmech.2026.118723_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.993","article-title":"Characterization of tr-107, a novel chemical activator of the human mitochondrial protease clpp","volume":"10","author":"Fennell","year":"2022","journal-title":"Pharmacol Res Perspect"},{"issue":"5","key":"10.1016\/j.ejmech.2026.118723_bib23","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.ccell.2019.03.014","article-title":"Mitochondrial clpp-mediated proteolysis induces selective cancer cell lethality","volume":"35","author":"Ishizawa","year":"2019","journal-title":"Cancer Cell"},{"issue":"11","key":"10.1016\/j.ejmech.2026.118723_bib24","doi-asserted-by":"crossref","first-page":"7629","DOI":"10.1021\/acs.jmedchem.1c02071","article-title":"Discovery of a novel series of imipridone compounds as homo sapiens caseinolytic protease p agonists with potent antitumor activities in vitro and in vivo","volume":"65","author":"Huang","year":"2022","journal-title":"J. Med. Chem."},{"issue":"9","key":"10.1016\/j.ejmech.2026.118723_bib25","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/j.chembiol.2022.07.002","article-title":"Aberrant human clpp activation disturbs mitochondrial proteome homeostasis to suppress pancreatic ductal adenocarcinoma","volume":"29","author":"Wang","year":"2022","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.ejmech.2026.118723_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115577","article-title":"Assessment of the structure-activity relationship and antileukemic activity of diacylpyramide compounds as human clpp agonists","volume":"258","author":"Zhang","year":"2023","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2026.118723_bib27","doi-asserted-by":"crossref","first-page":"7069","DOI":"10.1038\/s41467-023-42784-4","article-title":"Selective activator of human clpp triggers cell cycle arrest to inhibit lung squamous cell carcinoma","volume":"14","author":"Zhou","year":"2023","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.ejmech.2026.118723_bib28","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1021\/acs.jmedchem.3c01950","article-title":"Discovery of a novel series of homo sapiens caseinolytic protease p agonists for colorectal adenocarcinoma treatment via atf3-dependent integrated stress response","volume":"67","author":"Zhang","year":"2024","journal-title":"J. Med. Chem."},{"issue":"8","key":"10.1016\/j.ejmech.2026.118723_bib29","doi-asserted-by":"crossref","first-page":"6769","DOI":"10.1021\/acs.jmedchem.4c00338","article-title":"Rational design of a novel class of human clpp agonists through a ring-opening strategy with enhanced antileukemia activity","volume":"67","author":"Xiang","year":"2024","journal-title":"J. Med. Chem."},{"issue":"13","key":"10.1016\/j.ejmech.2026.118723_bib30","doi-asserted-by":"crossref","first-page":"10622","DOI":"10.1021\/acs.jmedchem.4c00080","article-title":"Discovery of 5-(piperidin-4-yl)-1,2,4-oxadiazole derivatives as a new class of human caseinolytic protease p agonists for the treatment of hepatocellular carcinoma","volume":"67","author":"Liu","year":"2024","journal-title":"J. Med. Chem."},{"issue":"23","key":"10.1016\/j.ejmech.2026.118723_bib31","doi-asserted-by":"crossref","first-page":"21009","DOI":"10.1021\/acs.jmedchem.4c01605","article-title":"Discovery of clpp-1071 as an exceptionally potent and orally efficacious human clpp activator with strong in vivo antitumor activity","volume":"67","author":"Chen","year":"2024","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2026.118723_bib32","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1021\/acs.jmedchem.4c02016","article-title":"Harnessing the magic methyl effect: discovery of clpp-2068 as a novel hsclpp activator for the treatment of diffuse large b-cell lymphoma","volume":"68","author":"Sun","year":"2025","journal-title":"J. Med. Chem."},{"issue":"45","key":"10.1016\/j.ejmech.2026.118723_bib33","doi-asserted-by":"crossref","first-page":"74380","DOI":"10.18632\/oncotarget.11814","article-title":"Discovery and clinical introduction of first-in-class imipridone onc201","volume":"7","author":"Allen","year":"2016","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.ejmech.2026.118723_bib34","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1038\/s41375-019-0491-z","article-title":"Imipridone onc212 activates orphan g protein-coupled receptor gpr132 and integrated stress response in acute myeloid leukemia","volume":"33","author":"Nii","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.ejmech.2026.118723_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107765","article-title":"Development of novel imipridone derivatives with potent anti-cancer activities as human caseinolytic peptidase p (hclpp) activators","volume":"153","author":"Zhang","year":"2024","journal-title":"Bioorg. Chem."},{"issue":"9","key":"10.1016\/j.ejmech.2026.118723_bib36","doi-asserted-by":"crossref","first-page":"4489","DOI":"10.1021\/jm3003697","article-title":"Methyl effects on protein-ligand binding","volume":"55","author":"Leung","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118723_bib37","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/cmdc.201290006","article-title":"Cover picture: discovery of [(2r,5r)\u20105\u2010{[(5\u2010fluoropyridin\u20102\u2010yl)oxy]methyl}\u20102\u2010methylpiperidin\u20101\u2010yl][5\u2010methyl\u20102\u2010(pyrimidin\u20102\u2010yl)phenyl]methanone (mk\u20106096): a dual orexin receptor antagonist with potent sleep\u2010promoting properties (chemmedchem 3\/2012)","volume":"7","author":"Coleman","year":"2012","journal-title":"ChemMedChem"},{"issue":"9","key":"10.1016\/j.ejmech.2026.118723_bib38","doi-asserted-by":"crossref","first-page":"5215","DOI":"10.1021\/cr200060g","article-title":"The methylation effect in medicinal chemistry","volume":"111","author":"Barreiro","year":"2011","journal-title":"Chem. Rev."},{"issue":"47","key":"10.1016\/j.ejmech.2026.118723_bib39","doi-asserted-by":"crossref","first-page":"12256","DOI":"10.1002\/anie.201303207","article-title":"Profound methyl effects in drug discovery and a call for new c-h methylation reactions","volume":"52","author":"Schonherr","year":"2013","journal-title":"Angew Chem. Int. Ed. Engl."},{"issue":"15","key":"10.1016\/j.ejmech.2026.118723_bib40","doi-asserted-by":"crossref","first-page":"4428","DOI":"10.1016\/j.bmcl.2008.06.048","article-title":"Biphenyl amide p38 kinase inhibitors 3: improvement of cellular and in vivo activity","volume":"18","author":"Angell","year":"2008","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"14","key":"10.1016\/j.ejmech.2026.118723_bib41","doi-asserted-by":"crossref","first-page":"5061","DOI":"10.1021\/jm100112j","article-title":"A medicinal chemist's guide to molecular interactions","volume":"53","author":"Bissantz","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118723_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2025.116855","article-title":"The mitochondrial protease clpp is a promising target for multiple myeloma treatment","volume":"236","author":"Liu","year":"2025","journal-title":"Biochem. Pharmacol."},{"issue":"9","key":"10.1016\/j.ejmech.2026.118723_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13092020","article-title":"Mitochondrial atp-dependent proteases-biological function and potential anti-cancer targets","volume":"13","author":"Feng","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.ejmech.2026.118723_bib44","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.cell.2016.07.002","article-title":"Mitochondria and cancer","volume":"166","author":"Vyas","year":"2016","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.ejmech.2026.118723_bib45","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1158\/0008-5472.CAN-18-0773","article-title":"Cd38-driven mitochondrial trafficking promotes bioenergetic plasticity in multiple myeloma","volume":"79","author":"Marlein","year":"2019","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.ejmech.2026.118723_bib46","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"Autodock vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"issue":"16","key":"10.1016\/j.ejmech.2026.118723_bib47","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/jcc.20291","article-title":"Gromacs: fast, flexible, and free","volume":"26","author":"Van Der Spoel","year":"2005","journal-title":"J. Comput. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2026.118723_bib48","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1021\/acs.jctc.9b00591","article-title":"Ff19sb: amino-acid-specific protein backbone parameters trained against quantum mechanics energy surfaces in solution","volume":"16","author":"Tian","year":"2020","journal-title":"J. Chem. Theor. Comput."},{"key":"10.1016\/j.ejmech.2026.118723_bib49","doi-asserted-by":"crossref","DOI":"10.1038\/s42004-020-0291-4","article-title":"Non-bonded force field model with advanced restrained electrostatic potential charges (resp2)","volume":"3","author":"Schauperl","year":"2020","journal-title":"Commun. Chem."},{"issue":"5","key":"10.1016\/j.ejmech.2026.118723_bib50","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/jcc.22885","article-title":"Multiwfn: a multifunctional wavefunction analyzer","volume":"33","author":"Lu","year":"2012","journal-title":"J. Comput. Chem."},{"issue":"10","key":"10.1016\/j.ejmech.2026.118723_bib51","doi-asserted-by":"crossref","first-page":"6281","DOI":"10.1021\/acs.jctc.1c00645","article-title":"Gmx_mmpbsa: a new tool to perform end-state free energy calculations with gromacs","volume":"17","author":"Valdes-Tresanco","year":"2021","journal-title":"J. Chem. Theor. Comput."},{"issue":"2","key":"10.1016\/j.ejmech.2026.118723_bib52","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1021\/acschembio.5b00757","article-title":"Barrel-shaped clpp proteases display attenuated cleavage specificities","volume":"11","author":"Gersch","year":"2016","journal-title":"ACS Chem. Biol."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426001686?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426001686?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T21:15:20Z","timestamp":1784668520000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426001686"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":52,"alternative-id":["S0223523426001686"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118723","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of 2-(methylamino)-5,6,7,8-tetrahydropyrido[4,3-d] pyrimidine derivatives as novel HsClpP activators for multiple myeloma therapy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118723","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118723"}}